Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

Artelo Biosciences Drug Helps Cancer Patients Regain Weight, Eyes Licensing Deal

lab, Medical,Hospital,Research,Laboratory:,Caucasian,And,Asian,Female,Scientists,Talking

Artelo Biosciences, Inc. (NASDAQ:ARTL) on Wednesday released interim results from its Phase 2 Cancer Appetite Recovery Study (CAReS) trial with ART27.13, the company’s peripherally acting cannabinoid receptor agonist for cancer anorexia-cachexia syndrome (CACS).

Affecting up to 80% of people living with cancer, CACS is marked by loss of appetite, weight loss and breakdown of muscle and fat.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.